http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2314829-C1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34 |
| filingDate | 2006-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2008-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2314829-C1 |
| titleOfInvention | Composition for treating spasmodic syndrome cases |
| abstract | FIELD: medicine. n SUBSTANCE: means has a benzodiazepine-class anticonvulsant like Sybazon, Phenazol and non-steroid anti-inflammatory means like Diclophenac, Celecoxib, Rofecoxib and Nimesulid adding ingredients in therapeutical doses. n EFFECT: reduced effective dose; avoided adverse side effects. n 3 cl, 4 tbl |
| priorityDate | 2006-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 88.